Journal of Bone and Mineral Metabolism

, Volume 24, Issue 2, pp 118–124 | Cite as

Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study

  • Katsumitsu Arai
  • Tadamasa Hanyu
  • Hiroya Sugitani
  • Takehiro Murai
  • Junichi Fujisawa
  • Kiyoshi Nakazono
  • Naoki Kondo
  • Naoto Endo


The occurrence of vertebral fracture was examined cross-sectionally and longitudinally over a 4-year interval in 117 menopausal and postmenopausal Japanese women with rheumatoid arthritis (RA), whose ages ranged from 50 to 64 years. Patients treated with bisphosphonate were excluded. Vertebral fracture was diagnosed by lateral thoracic and lumbar spine radiography at the start and end of a 4-year period. Bone mineral density (BMD) at L2–L4 according to dual-energy X-ray absorptiometry (DXA), the administration of corticosteroids or methotrexate, and urinary excretion of N-telopeptide of type I collagen (NTx) were also recorded. In the cross-sectional study, the prevalence of vertebral fracture in the initial radiographs of RA patients was 21%, while it was 5% in healthy age-matched controls. Among RA patients treated with corticosteroids, 33% had vertebral fracture, which was a significantly higher prevalence than that in RA patients without steroid administration. In the longitudinal study, vertebral fracture prevalence was also increased in patients more than 60 years old. RA patients having steroid treatment and a BMD/YAM (young adult mean) ratio below 70% had higher risk of vertebral fracture than patients with a BMD/YAM ratio of 70%–80%, which in turn exceeded the risk with a BMD of 80% or more. No adverse effect of low-dose methotrexate on vertebral fracture was found. Urinary NTx was high in RA patients, as reported previously, and did not differ between patients with or without new fracture after 4 years. In conclusion, Japanese RA patients more than 60 years old who were treated with corticosteroid or had a BMD below 80% had high risk of vertebral fracture.

Key words

rheumatoid arthritis vertebral fracture steroid administration postmenopausal age longitudinal study design 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hanyu, T, Arai, K, Takahashi, HE 1999Structural mechanisms of bone loss in iliac biopsies: comparison between rheumatoid arthritis and postmenopausal osteoporosisRheum Int18193200Google Scholar
  2. 2.
    Kanis, JA, Johansson, H, Oden, A, Johnell, O, de Laet, C, Melton, LJ,III, Tenenhouse, A, Reeve, J, Silman, AJ, Pols, HA, Eisman, JA, McCloskey, EV, Mellstrom, D 2004A meta-analysis of prior corticosteroid use and fracture riskJ Bone Miner Res19893899PubMedGoogle Scholar
  3. 3.
    Ørstavik, RE, Haugeberg, G, Mowinckel, P, Hoiseth, A, Uhlig, T, Falch, JA, Halse, JI, McCloskey, E, Kvien, TK 2004Vertebral deformities in rheumatoid arthritis: a comparison with population-based controlsArch Intern Med164420425PubMedGoogle Scholar
  4. 4.
    Haugeberg, G, Uhlig, T, Falch, JA, Halse, JI, Kvien, TK 2000Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritisArthritis Rheum43522530PubMedGoogle Scholar
  5. 5.
    Gough, AK, Lilley, J, Eyre, S, Holder, RL, Emery, P 1994Generalised bone loss in patients with early rheumatoid arthritisLancet3442327CrossRefPubMedGoogle Scholar
  6. 6.
    Shenstone, BD, Mahmoud, A, Woodward, R, Elvins, D, Palmer, R, Ring, EF, Bhalla, AK 1994Longitudinal bone mineral density changes in early rheumatoid arthritisBr J Rheumatol33541545PubMedGoogle Scholar
  7. 7.
    Sambrook, PN, Cohen, ML, Eisman, JA, Pocock, NA, Champion, GD, Yeates, MG 1989Effects of low-dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal studyAnn Rheum Dis48535538PubMedGoogle Scholar
  8. 8.
    Aman, S, Hakala, M, Silvennoinen, J, Manelius, J, Risteli, L, Risteli, J 1998Low incidence of osteoporosis in a 2-year follow-up of early community-based patients with rheumatoid arthritisScand J Rheumatol27188193PubMedGoogle Scholar
  9. 9.
    Cortet, B, Guyot, MH, Solau, E, Pigny, P, Dumoulin, F, Flipo, RM, Marchandise, X, Delcambre, B 2000Factors influencing bone loss in rheumatoid arthritis: a longitudinal studyClin Exp Rheumatol18683690PubMedGoogle Scholar
  10. 10.
    Mazzantini, M, Di Munno, O, Incerti-Vecchi, L, Pasero, G 2000Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexateClin Exp Rheumatol18327331PubMedGoogle Scholar
  11. 11.
    van Schaardenburg, D, Valkema, R, Dijkmans, BA, Papapoulos, S, Zwinderman, AH, Han, KH, Pauwels, EK, Breedveld, FC 1995Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatmentArthritis Rheum38334342PubMedGoogle Scholar
  12. 12.
    Kroot, EJ, Nieuwenhuizen, MG, de Waal Malefijt, MC, van Riel, PL, Pasker-de Jong, PC, Laan, RF 2001Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the diseaseArthritis Rheum4412541260CrossRefPubMedGoogle Scholar
  13. 13.
    de Nijs, RN Jacobs, JW Bijlsma, JW Lems, WF Laan, RF Houben, HH ter Borg, EJ Huisman, AM Bruyn, GA van Oijen, PL Westgeest, AA Algra, A Hofman, DM Osteoporosis Working GroupDutch Society for Rheumaology2001Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid-treated patients with rheumatoid arthritisRheumatology4013751383CrossRefPubMedGoogle Scholar
  14. 14.
    Iga, T, Dohmae, Y, Endo, N, Takahashi, HE 1999Increase in the incidence of cervical and trochanteric fractures of the proximal femur in Niigata Prefecture, JapanJ Bone Mineral Metab17224231Google Scholar
  15. 15.
    Morita, Y, Endo, N, Iga, T, Tokunaga, K, Ohkawa, Y 2002The incidence of cervical and trochanteric fractures of proximal femur in 1999 in Niigata Prefecture, JapanJ Bone Mineral Metab20311318Google Scholar
  16. 16.
    Arnett, FC, Edworthy, SM, Bloch, DA, McShane, DJ, Fries, JF, Cooper, NS, Healey, LA, Kaplan, SR, Liang, MH, Luthra, HS, Medsger, TA,Jr, Mitchell, DM, Neustadt, DH, Pinals, RS, Schaller, JG, Sharp, JT, Wilder, RL, Hunder, GG 1988The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum31315324PubMedGoogle Scholar
  17. 17.
    Orimo, H, Sugioka, Y, Fukunaga, M, Muto, Y, Hotokebuchi, T, Gorai, I, Nakamura, T, Kushida, K, Tanaka, H, Ikai, T, Oh-hashi, Y 1998Diagnostic criteria of primary osteoporosisJ Bone Mineral Metab16139150Google Scholar
  18. 18.
    Nawata, H, Soen, S, Takayanagi, R, Tanaka, I, Takaoka, K, Fukunaga, M, Matsumoto, T, Suzuki, Y, Tanaka, H, Fujiwara, S, Miki, T, Sagawa, A, Nishizawa, Y, Seino, Y 2005Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004)J Bone Miner Metab23105109CrossRefPubMedGoogle Scholar
  19. 19.
    Kanis, JA, Johnell, O, De Laet, C, Johansson, H, Oden, A, Delmas, P, Eisman, J, Fujiwara, S, Garnero, P, Kroger, H, McCloskey, EV, Mellstrom, D, Melton, LJ, Pols, H, Reeve, J, Silman, A, Tenenhouse, A 2004A meta-analysis of previous fracture and subsequent fracture riskBone35375382PubMedGoogle Scholar
  20. 20.
    Cohen, S, Levy, RM, Keller, M, Boling, E, Emkey, RD, Greenwald, M, Zizic, TM, Wallach, S, Sewell, KL, Lukert, BP, Axelrod, DW, Chines, AA 1999Risedronate therapy prevents corticosteroid-induced bone lossArthritis Rheum4223092318CrossRefPubMedGoogle Scholar
  21. 21.
    Reid, DM, Hughes, RA, Laan, RF, Sacco-Gibson, NA, Wenderoth, DH, Adami, S, Eusebio, RA, Devogelaer, JP 2000Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trialJ Bone Miner Res1510061013PubMedGoogle Scholar
  22. 22.
    Ecklund, K, Laor, T, Goorin, AM, Connolly, LP, Jaramillo, D 1997Methotrexate osteopathy in patients with osteosarcomaRadiology202543547PubMedGoogle Scholar
  23. 23.
    Schwartz, AM, Leonidas, JC 1984Methotrexate osteopathySkeletal Radiol111316CrossRefPubMedGoogle Scholar
  24. 24.
    Preston, SJ, Diamond, T, Scott, A, Laurent, MR 1993Methotrexate osteopathy in rheumatic diseaseAnn Rheum Dis52582585PubMedGoogle Scholar
  25. 25.
    Shapira, D, Scharf, Y 1995Insufficiency fracture of the distal tibia mimicking arthritis in a rheumatoid arthritis patient. The possible role of methotrexate treatmentClin Exp Rheumatol13130131PubMedGoogle Scholar
  26. 26.
    Maenaut, K, Westhovens, R, Dequeker, J 1996Methotrexate osteopathy: does it exist?J Rheumatol2321562159PubMedGoogle Scholar
  27. 27.
    Alonso-Bartolome, P, Martinez-Taboada, VM, Blanco, R, Rodriguez-Valverde, V 1999Insufficiency fractures of the tibia and fibulaSemin Arthritis Rheum28413420PubMedGoogle Scholar
  28. 28.
    Buckley, LM, Leib, ES, Cartularo, KS, Vacek, PM, Cooper, SM 1997Effects of low-dose methotrexate on the bone mineral density of patients with rheumatoid arthritisJ Rheumatol2414891494PubMedGoogle Scholar
  29. 29.
    Minaur, NJ, Kounali, D, Vedi, S, Compston, JE, Beresford, JN, Bhalla, AK 2002Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral densityRheumatology41741749PubMedGoogle Scholar
  30. 30.
    Gough, A, Sambrook, P, Devlin, J, Huissoon, A, Njeh, C, Robbins, S, Nguyen, T, Emery, P 1998Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritisJ Rheumatol2512821289PubMedGoogle Scholar
  31. 31.
    Hein, G, Franke, S, Muller, A, Brauning, E, Eidner, T, Stein, G 1997The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritisClin Rheumatol16167172CrossRefPubMedGoogle Scholar
  32. 32.
    Suzuki, M, Takahashi, M, Miyamoto, S, Hoshino, H, Kushida, K, Miura, M, Inoue, T 1998The effects of menopause status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritisBr J Rheumatol37653658CrossRefPubMedGoogle Scholar
  33. 33.
    Iwamoto, J, Takeda, T, Ichimura, S 2003Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritisJ Calcif Tissue Int72491497Google Scholar

Copyright information

© Springer-Verlag Tokyo 2006

Authors and Affiliations

  • Katsumitsu Arai
    • 1
  • Tadamasa Hanyu
    • 2
  • Hiroya Sugitani
    • 3
  • Takehiro Murai
    • 1
  • Junichi Fujisawa
    • 1
  • Kiyoshi Nakazono
    • 4
  • Naoki Kondo
    • 1
  • Naoto Endo
    • 1
  1. 1.Division of Orthopedic Surgery, Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataJapan
  2. 2.Department of RheumatologyNagaoka Red Cross HospitalNagaokaJapan
  3. 3.Department of Orthopedic SurgeryNiigata Prefectural Central HospitalJoetsuJapan
  4. 4.Department of RheumatologyNiigata Prefectural Senami HospitalMurakamiJapan

Personalised recommendations